{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:10Z","timestamp":1793377870038,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejso.2026.112027","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:23:47Z","timestamp":1784615027000},"page":"112027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant therapy vs. surgery alone for esophageal squamous cell carcinoma undergoing thoracoscopic esophagectomy:An overlap weighting analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Mengyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peinan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.112027_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2026.112027_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cac2.12627","article-title":"Cancer situation in China: an analysis based on the global epidemiological data released in 2024","volume":"45","author":"Diao","year":"2024","journal-title":"Cancer Commun"},{"issue":"3","key":"10.1016\/j.ejso.2026.112027_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2022.02.009","article-title":"JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma","volume":"40","author":"Yamamoto","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ejso.2026.112027_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gie.2020.01.012","article-title":"A retrospective cohort study of endoscopic therapy and esophagectomy for stage 1 esophageal cancer: less is more","volume":"92","author":"McCarty","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.ejso.2026.112027_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jtho.2022.10.018","article-title":"Robotic esophagectomy compared with open esophagectomy reduces Sarcopenia within the first postoperative year: a propensity score-matched analysis","volume":"18","author":"Merboth","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112027_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0000000000003222","article-title":"Can minimally invasive esophagectomy replace open esophagectomy for esophageal cancer? Latest analysis of 24,233 esophagectomies from the Japanese national clinical database","volume":"272","author":"Yoshida","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.112027_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial","volume":"34","author":"Tang","year":"2023","journal-title":"Ann Oncol"},{"issue":"Pt A","key":"10.1016\/j.ejso.2026.112027_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijsu.2018.04.053","article-title":"Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options","volume":"54","author":"Mota","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.112027_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1509051","article-title":"Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy","volume":"15","author":"Hampe","year":"2024","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112027_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.26090","article-title":"Variation in diagnosis, treatment, and outcome of esophageal cancer in a regionalized care system in Ontario, Canada","volume":"4","author":"Habbous","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ejso.2026.112027_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/SLA.0000000000005227","article-title":"Role of adjuvant therapy in esophageal cancer patients after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis","volume":"275","author":"Lee","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.112027_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijrobp.2024.12.036","article-title":"Proton radiotherapy significantly reduces pneumonia in patients with esophageal cancer","volume":"122","author":"Frederiks","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.ejso.2026.112027_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2026.112027_bib14","doi-asserted-by":"crossref","first-page":"8387","DOI":"10.1245\/s10434-021-10194-9","article-title":"Optimal treatment of cT2N0 esophageal carcinoma: is upfront surgery really the way?","volume":"28","author":"Capovilla","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112027_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.athoracsur.2019.04.008","article-title":"Neoadjuvant therapy Vs upfront surgery for clinical T2N0 esophageal cancer: a systematic review","volume":"108","author":"Kidane","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejso.2026.112027_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108591","article-title":"Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: a multidimensional perspective","volume":"254","author":"Yang","year":"2024","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejso.2026.112027_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80653-2","article-title":"Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer","volume":"14","author":"Lin","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ejso.2026.112027_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40487-025-00366-y","article-title":"A practical approach to understanding real-world study methodology in cancer research: a vodcast","volume":"13","author":"Brufsky","year":"2025","journal-title":"Oncol Ther"},{"issue":"10","key":"10.1016\/j.ejso.2026.112027_bib19","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41592-024-02405-4","article-title":"Propensity score matching","volume":"21","author":"Kurz","year":"2024","journal-title":"Nat Methods"},{"issue":"23","key":"10.1016\/j.ejso.2026.112027_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ejso.2026.112027_bib21","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1245\/s10434-025-17567-4","article-title":"Survival comparison between open and thoracoscopic esophagectomy for esophageal squamous cell carcinoma stratified by pathological tumor\u2013node\u2013metastasis stage: an overlap weighting analysis","volume":"32","author":"Jia","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112027_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"Strocss 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2026.112027_bib23","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1007\/s00432-023-04765-4","article-title":"Left compared with right thoracic approach thoracotomy in esophageal cancer: a retrospective cohort study","volume":"149","author":"Yang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112027_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejso.2026.112027_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpg.2018.11.005","article-title":"Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer","volume":"36\u201337","author":"van den Ende","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.ejso.2026.112027_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/JS9.0000000000000311","article-title":"Weight loss during neoadjuvant therapy and short-term outcomes after esophagectomy: a retrospective cohort study","volume":"109","author":"Hirano","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.112027_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106680","article-title":"Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: a prospective, single-arm, phase II study (TD-NICE)","volume":"103","author":"Yan","year":"2022","journal-title":"Int J Surg"},{"issue":"23","key":"10.1016\/j.ejso.2026.112027_bib28","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.20.00866","article-title":"Treatment of locally advanced Esophageal Carcinoma: ASCO guideline","volume":"38","author":"Shah","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112027_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/SLA.0000000000002435","article-title":"Recurrence patterns and long-term results after induction chemotherapy, chemoradiotherapy, and curative surgery in patients with locally advanced esophageal cancer","volume":"269","author":"Steffen","year":"2019","journal-title":"Ann Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:33:42Z","timestamp":1793374422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326006463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0748798326006463"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112027","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant therapy vs. surgery alone for esophageal squamous cell carcinoma undergoing thoracoscopic esophagectomy:An overlap weighting analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112027"}}